期刊文献+

淋球菌对头孢克肟等6种抗生素敏感性及耐药质粒分型研究 被引量:12

In Vitro Susceptibility to 6 Antimicrobial Agents and the Resistance Plasmids Genotype of Neisseria gonorrhoeae Isolates from 4 Cities in Guangdong
下载PDF
导出
摘要 目的:检测2011年广东省广州、佛山、江门、肇庆四市临床分离的淋球菌流行株对青霉素、四环素、环丙沙星、头孢克肟、头孢曲松和大观霉素等6种抗生素的敏感性,对质粒介导的产β-内酰胺酶淋球菌(PPNG)和四环素高水平耐药淋球菌(TRNG)进行耐药质粒TEM-1和tetM基因分型。方法:采用琼脂稀释法测定菌株对6种抗菌药物的最小抑菌浓度(MIC),判断敏感性按WHO西太区淋球菌耐药性监测统一标准,其中头孢克肟敏感性试验和判断标准按美国临床和实验室标准化研究所(CLSI)判断。用纸片酸度法检测产β-内酰胺酶淋球菌(PPNG)菌株,多重PCR方法鉴定β-内酰胺酶质粒并进行TEM-1和TRNG tetM基因分型。结果:来自四市429株淋球菌中检出青霉素耐药364株(84.8%),四环素和环丙沙星耐药株(率)分别为389株(90.7%)和418株(97.4%),未发现对大观霉素、头孢克肟和头孢曲松耐药菌株,但头孢曲松低敏率达到34.0%(146/429),头孢克肟低敏只有1株(0.2%)。青霉素、四环素和环丙沙星的MIC50及MIC90均已超过耐药标准。检出PPNG株156株(36.4%),TRNG株201株(46.9%)。耐药质粒TEM-1基因分型以亚洲型为主(94.9%,148/156),只有8株携带非洲型质粒;tetM基因分型均为荷兰型。结论:四市淋球菌对青霉素、四环素和环丙沙星耐药率较高,对大观霉素、头孢克肟和头孢曲松的敏感性较高,TEM-1基因质粒分型以亚洲型为主,tetM基因分型均为荷兰型。 Objective:To assess the in vitro susceptibility to 6 antimicrobial agents and TEM-1, tetM genotypes of clinical isolates of Neisseria gonorrhoeae from 4 cities in Guangdong province in 2011. Methods :The agar dilution method was used to determine the minimum inhibitory concentrations (MICs) to six antibiotics, penicillin G, tetracycline, ciprofloxaein, cefixime, ceftriaxone and spectinomycin. The susceptibility of all strains to five antibiotics was interpreted according to criteria adopted in the project of surveillance of gonococcal antibiotic susceptibility in the WHO Western Pacific Region and cefixime susceptibility was interpreted as Clinical and Laboratory Standards Institute (CLSI). Penicillinase (β-lactamase) -producing N. gonorrhoeae (PPNG) was analysed by the paper acidometric method. A multi-PCR was used to distinguish subtypes of TEM-1 and tetM. Results: 429 strains of N. gonorrhoeae collected from Guangzhou, Foshan, Jiangmen and Zhaoqin in Guangdong province were studied. 364 isolates (84. 8% ) showed resist, ance to penicillin. The prevalence of tetracycline- and ciprofloxacin-resistance was 90. 7% and 97.4%, while none of the strains appeared to be resistant to spectinomycin, cefixime and ceftriaxone, respectively, but 146(34.0% ) and 1 (0. 2% ) showed reduced sensitivity to ceftriaxone and cefixime. MIC50 and MIC90 of penicillin, tetracycline and ciprofloxacin were significantly higher than resistant standards. 156(36.4% ) strains were PPNG and 201 (46.9%) strains were TRNG. Subtyping of TEM-1 gene in β-lactamase plasmids of PPNG showed that 148 (94. 9% ) PPNGs carried the Asian-type plasmids while African-type plasmid was found in only 8 strains. Subtyping of tetM gene showed that all 201 TRNGs were Dutch variant. Conclusion:Resistance to penicillin, tetracycline and ciprofloxacin spreads seriously in four cities of Guangdong province. The isolates of N. gonorrhoeae show better susceptibility to spectiomycin, cefixime and ceftriaxone. The Asian-type β - lactamase plasmids are dominant in PPNG, while African-type plasmid is sporadic. All of the TRNGs carry the Dutch variant plasmid.
出处 《皮肤性病诊疗学杂志》 2012年第6期352-355,358,共5页 Journal of Diagnosis and Therapy on Dermato-venereology
基金 广东省医学科研基金项目(编号:B2010049)
关键词 奈瑟氏球菌 淋病 微生物敏感性试验 TEM-1 Neisseria gonorrhoeae Microbial susceptibility tests TEM-1
  • 相关文献

参考文献16

  • 1World Health Organization. Sensitivty testing of Neisseria gonorrhoeae: methodologies for use by participants in the WHO Western Pacific Regional Surveillance Programme [ S ]. In: WHO/WPR Regional Antimicrobial Surevil- lance Working Group Meeting Proceedings, 1992:33.
  • 2Clinical and Laboratory Standards Institute. MIO0-S15 Performance standards for antimicrobial susceptibility tes- ting; fifteenth informational supplement [ S]. Wayne, Pa. Clinical and Laboratory standards Institute, 2010.
  • 3Palmer HM, Leeming JP, Turner A. Amultiplex poly- merase chain reaction to differentiate -lactamase plas- mids of Neisseria gonorrhoeae [ J ]. Antimicrob Chemoth- er,2000,45:777-782.
  • 4Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future of untreatable gonorrhea? Detaild characterization of the first strain with high-level resistance to ceftriaxone [ J ]. Antimicrob Agents che- mother 2011,55 (7) :3538-3545.
  • 5韩燕,尹跃平,戴秀芹,袁柳凤,向志,陈祥生.2008年中国淋球菌临床分离株耐药性的流行病学研究[J].中华皮肤科杂志,2011,44(7):472-475. 被引量:22
  • 6Bolan GA, Sparling PF, Wasserheit JN. The emerging threat of untreatable Gonococcal infection. [ J ]. N ENGL J MED, 2012,366(6) :485-487.
  • 7Australian Gonococcal Surveillance Programme, Tapsall J. Annual report of the Australian Gonococcal Surveil- lance Programme, 2008 [ J ]. Commun Dis Intell, 2009, 33(3) : 268-274.
  • 8初瑞雪,孟卫东.某地区淋球菌流行株耐药性及质粒谱型研究[J].国际检验医学杂志,2011,32(2):203-204. 被引量:10
  • 9吴兴中,郑和平,曾维英,黄进梅,潘慧清,李美玲.淋球菌流行株抗生素敏感性监测[J].岭南皮肤性病科杂志,2008,15(3):121-123. 被引量:6
  • 10吴兴中,郑和平,黄进梅,曾维英,薛耀华,潘慧清,李美玲.质粒介导产β-内酰胺酶淋球菌的检测及其TEM-1基因质粒分型[J].中华皮肤科杂志,2010,43(5):363-365. 被引量:5

二级参考文献58

共引文献39

同被引文献83

  • 1栗晓冬.头孢替唑钠联合左氧氟沙星片治疗淋病126例分析[J].黑龙江医药科学,2009,32(5):88-89. 被引量:2
  • 2谢裕南,张流明,林蔼,邓景航.头孢唑肟钠治疗单纯性淋病60例疗效观察[J].岭南皮肤性病科杂志,2004,11(2):169-170. 被引量:2
  • 3裴广德.头孢派酮舒巴坦治疗单纯性淋病剂量探讨[J].中国皮肤性病学杂志,2006,20(5):292-293. 被引量:5
  • 4杜红,梁德雄,吴念宁.口服头孢克肟联合三金片治疗尿路感染43例疗效观察[J].实用医技杂志,2006,13(18):3151-3153. 被引量:7
  • 5张铁军,周晓明,张涛,姜庆五.淋球菌分离株耐药质粒谱型研究[J].中国皮肤性病学杂志,2007,21(3):144-146. 被引量:8
  • 6Bai ZG, Bao X, Cheng WD, et al. Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea: A meta - analysis of randomized controlled trials. International journal of STD,2012,23(2) :126 - 132.
  • 7World Health Organization. Sensitivty testing of Neisseria gonorrhoeae: methodologies for use by participants in the WHO Western Pacific Regional Surveillance Programme [ S ]. In: WHO/WPR Regional Antimicrobial Surevil- lance Working Group Meeting Proceedings, 1992.33.
  • 8Clinical and Laboratory Standards Institute. M100-S15 Performance standards for antimicrobial susceptibility tes- ting; fifteenth informational supplement [ S ]. Wayne,Pa. Clinical and Laborary Standards Institute, 2010.
  • 9Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a futureera of untreatable gonorrhe- a? Detailed characterization of the first strain with high- level resistance to ceftriaxone [ J ]. Antimicrob Agents Chemother, 2011,55 ( 7 ) :3538-3545.
  • 10Bolan GA, Sparling PF, Wassrheit JN, et al. The emer- ging threat of untreatable gonococcal infection [ J ].N En- gl J Med, 2012,366(6) :485-487.

引证文献12

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部